| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070643 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
Every fourth patient will have residual disease in the axilla, 10% even large metastases, if axillary clearance is omitted in patients with SN micrometastases. The risk of NSN involvement seems negligible in patients with a single SN micrometastasis and four or more healthy SN harvested.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.H.K. Leidenius, J.H. Vironen, M.S. Riihelä, L.A. Krogerus, T.S. Toivonen, K.A.J. von Smitten, P.S. Heikkilä,